Stocks to sell

QuantumScape (NYSE:QS), a startup founded a decade ago, touts a game-changing solid-state battery tech for EVs. However, it’s unproven at scale and faces lawsuits over alleged fraud. A recent $300 million equity offering raised concerns about dilution. Investing in QuantumScape may seem like a binary bet, hinging on whether they successfully bring a solid-state battery
0 Comments
High-interest rates are here to stay for the foreseeable future. Financial services stocks promise to be some of the most affected by the Fed’s pronouncement. Though markets dipped hard this week and portend further downside, some financial services stocks haven’t yet had a complete reckoning. Rate hikes affect multiple aspects of typical financial services companies.
0 Comments
The IPO market in 2023 has been anything but hot. After a record-breaking year in 2021, the appetite for new listings has cooled down significantly, first in 2022 and continuing into the current year. Several factors have contributed to this slowdown, such as rising interest rates, inflation fears, geopolitical tensions, regulatory uncertainties and what some
0 Comments
As I’ve noted previously, artificial intelligence (AI) will be tremendously positive for most companies. That’s because the technology will enable companies to provide their customers with better service, more efficiently make and transport products and acquire new customers much more efficiently and effectively. However, AI will badly hurt other firms because the technology will make
0 Comments
The healthcare industry has historically provided significant returns to investors. And, it is currently boasting a compounding annual growth rate prediction of 10.4% until 2027. Despite having many extremely profitable companies that see a surge in stock price, there are also many healthcare stocks that plummet. This is because many healthcare companies rely on trials
0 Comments
With recession fears on the rise, now might be a good time to consider the top retail stocks to sell in 2023. Indeed, with retail buyer’s consumption patterns shifting, many investors are beginning to take a step back. The macroeconomic landscape is not what it was pre-pandemic, and consumers are spending less on non-essentials and more on
0 Comments
With the potential for consumer spending to decrease in the months ahead, uncertainty is rising with consumer stocks. Sure, U.S. consumers have been resilient despite challenges such as high inflation and rising interest rates. However, this resilience may morph into weakness. Just this week, the Conference Board announced that the Consumer Confidence Index just hit
0 Comments
It’s important to keep a look out for dividend stocks to sell in your portfolio. I’ll always believe that there’s nothing better than a quality dividend stock, one that not only provides a decent return but also has a solid dividend history to reward shareholders. That’s why I will also be disappointed in a poor
0 Comments
Despite the industrial sector playing a less outsized role in the American economy, it still is a major force in global economy. The industrial sector simply refers to companies at the heart of the economy. They produce goods and services for various industries such as aerospace, construction, mining, transportation and manufacturing. However, not all industrial
0 Comments
Apparently, electric vehicle (EV) manufacturer Mullen Automotive (NASDAQ:MULN) is expanding its business operations into a new area — again. The MULN stock bulls might celebrate this, but consider the big picture. All in all, the risk-to-reward balance still doesn’t favor Mullen Automotive and its investors. I’ll admit, there may be a news item or two
0 Comments
Small-cap stocks are a perennial favorite among retail investors. On average, small-cap stocks (as a category) outperform the overall market over a long enough period. Since analysts began breaking down market capitalization by category in the US, small-cap stocks returned more than 17% annually on average.  However, the upside potential is coupled with greater downside
0 Comments